(PROSPECTOR) Screening Study Evaluating the Prevalence of the KIT D816V Mutation in Patients With Systemic Mast Cell Activation
NCT04811365
·
clinicaltrials.gov ↗
COMPLETED
Status
379
Enrollment
INDUSTRY
Sponsor class
Conditions
Systemic Mast Cell Activation
KIT D816V Mutation
Interventions
OTHER:
Screening
Sponsor
Blueprint Medicines Corporation